Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JOYY
751
JOYY Inc
JOYY
$3.75B
| $134M | 0.01% |
1,518,047
+479,703
| +46% | +$32M |
|
752
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
| $134M | 0.01% |
1,022,929
-809,932
| -44% | -$98M |
|
753
Principal Financial Group
PFG
$24.3B
| $134M | 0.01% |
3,215,329
+514,528
| +19% | +$18.8M |
|
754
DXC Technology
DXC
$1.73B
| $133M | 0.01% |
8,064,105
-332,179
| -4% | -$5.28M |
|
755
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.3B
| $133M | 0.01% |
10,276,085
-6,084,591
| -37% | -$73.9M |
|
|
DAY
756
DELISTED
Dayforce
DAY
| $133M | 0.01% |
1,676,411
-282,348
| -14% | -$18.1M |
|
757
SLM Corp
SLM
$5.15B
| $133M | 0.01% |
18,873,556
-4,132,350
| -18% | -$30.9M |
|
758
Assurant
AIZ
$14.3B
| $132M | 0.01% |
1,280,347
+104,451
| +9% | +$10.8M |
|
759
Xylem
XYL
$28.1B
| $132M | 0.01% |
2,034,723
-197,960
| -9% | -$13.1M |
|
760
West Pharmaceutical
WST
$24.9B
| $132M | 0.01% |
580,698
+573,372
| +7,827% | +$113M |
|
|
RDFN
761
DELISTED
Redfin
RDFN
| $132M | 0.01% |
3,145,852
+250,543
| +9% | +$6.6M |
|
762
Kura Oncology
KURA
$850M
| $132M | 0.01% |
8,084,683
+1,270,477
| +19% | +$18.3M |
|
763
Element Solutions
ESI
$9.23B
| $132M | 0.01% |
12,140,325
+697,400
| +6% | +$7M |
|
764
Baker Hughes
BKR
$61.1B
| $131M | 0.01% |
8,540,671
+32,286
| +0.4% | +$472K |
|
|
PINC
765
DELISTED
Premier
PINC
| $131M | 0.01% |
3,825,286
-436,403
| -10% | -$14.3M |
|
766
CrowdStrike
CRWD
$218B
| $131M | 0.01% |
5,228,940
+313,004
| +6% | +$6.28M |
|
767
Passage Bio
PASG
$14.1M
| $130M | 0.01% |
238,422
+81,716
| +52% | +$36.7M |
|
768
F5
FFIV
$22.7B
| $130M | 0.01% |
929,039
+99,938
| +12% | +$13.5M |
|
769
Outfront Media
OUT
$5.5B
| $129M | 0.01% |
9,274,624
+836,108
| +10% | +$11.7M |
|
770
AXIS Capital
AXS
$7.55B
| $129M | 0.01% |
3,182,080
+491,400
| +18% | +$18.9M |
|
771
iShares MSCI China ETF
MCHI
$6.38B
| $128M | 0.01% |
1,960,282
-435,404
| -18% | -$26.7M |
|
772
Arvinas
ARVN
$572M
| $128M | 0.01% |
3,824,462
+1,122,563
| +42% | +$47.7M |
|
773
Toll Brothers
TOL
$14.5B
| $128M | 0.01% |
3,927,429
+2,344,779
| +148% | +$64.1M |
|
|
PFPT
774
DELISTED
Proofpoint, Inc.
PFPT
| $128M | 0.01% |
1,149,787
+315,951
| +38% | +$36.1M |
|
775
Public Service Enterprise Group
PEG
$37.7B
| $128M | 0.01% |
2,598,153
+1,685,627
| +185% | +$84M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.